99m Tc-EDDA-HYNIC-D-Phe 1 ,Tyr 3 ]-Octreotide ( 99m Tc-EDDA/HYNIC-TOC) is a promising new radiopharmaceutical with the potential to replace [ 111 In-DTPA-D-Phe 1 ]-Octreotide ( 111 In-DTPA-OCT) as the radiopharmaceutical for somatostatin receptor scintigraphy due to the advantage of improved image
✦ LIBER ✦
Analytical monitoring of the quality of the radiopharmaceutical99mTc-HEDP for radionuclide diagnosis of bone pathology
✍ Scribed by N. B. Épshtein; E. I. Morosanova; Y. Ya; Kharitonov; T. V. Terekhova; V. G. Skvortsov
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 115 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0091-150X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Radiopharmaceutical development of a fre
✍
Elisabeth Von Guggenberg; Renata Mikolajczak; Barbara Janota; Georg Riccabona; C
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
English
⚖ 150 KB
Radiopharmaceutical development of a fre
✍
Von Guggenberg, Elisabeth (author);Mikolajczak, Renata (author);Janota, Barbara
📂
Article
📅
2004
🏛
John Wiley and Sons Inc.
🌐
English
⚖ 150 KB
Quality-by-Design (QbD): An integrated p
✍
Huiquan Wu; Mansoor A. Khan
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 359 KB
👁 1 views
In this work, an integrated PAT approach was developed for monitoring a pharmaceutical (naproxen) and a polymer (eudragit) coprecipitation process: real-time in-line near-infrared (NIR) absorbance monitoring, real-time on-line turbidity monitoring, and in situ crystal size monitoring. The data and i